Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Halfon, P' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 88 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lafeuillade, A; Halfon, P; Chadapaud, S; Hittinger, G; Khiri, H; Poggi, C
      Potential adverse effects of structured therapeutic interruptions on the pool of HIV-infected cells

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    2. Halfon, P; Eggli, Y
      Screening inappropriate hospital days on the basis of routinely available data

      INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE
    3. Lafeuillade, A; Khiri, H; Chadapaud, S; Hittinger, G; Halfon, P
      Persistence of HIV-1 resistance in lymph node mononuclear cell RNA despiteeffective HAART

      AIDS
    4. Halfon, P; Trimoulet, P; Bourliere, M; Khiri, H; de Ledinghen, V; Couzigou, P; Feryn, JM; Alcaraz, P; Renou, C; Fleury, HJA; Ouzan, D
      Hepatitis C virus genotyping based on 5 ' noncoding sequence analysis (Trugene)

      JOURNAL OF CLINICAL MICROBIOLOGY
    5. Halfon, P; Riflet, H; Renou, C; Quentin, Y; Cacoub, P
      Molecular evidence of male-to-female sexual transmission of hepatitis C virus after vaginal and anal intercourse

      JOURNAL OF CLINICAL MICROBIOLOGY
    6. Renou, C; Muller, P; Louve, E; Bertrand, JJ; Raoult, A; Benderriter, T; Halfon, P
      Relevance of moderate isolated thrombopenia as a strong predictive marker of cirrhosis in patients with chronic hepatitis C virus

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    7. Clevenbergh, P; Durant, J; Halfon, P; del Giudice, P; Mondain, V; Montagne, N; Schapiro, JM; Boucher, CAB; Dellamonica, P
      Persisting long-term benefit of genotype-guided treatment for HIV-infectedpatients failing HAART. The Viradapt study: week 48 follow-up

      ANTIVIRAL THERAPY
    8. Durant, J; Clevenbergh, P; Garraffo, R; Halfon, P; Icard, S; Del Giudice, P; Montagne, N; Schapiro, JM; Dellamonica, P
      Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the ViradaptStudy

      AIDS
    9. Halfon, P; Cacoub, P
      Quantitation of hepatitis C virus RNA: present and future.

      REVUE DE MEDECINE INTERNE
    10. Lefrere, JJ; Lerable, J; Mariotti, M; Bogard, M; Thibault, V; Frangeul, L; Loiseau, P; Bouchardeau, F; Laperche, S; Pawlotsky, JM; Cantaloube, JF; Biagini, P; de Lamballerie, X; Izopet, J; Defer, C; Lepot, I; Poveda, JD; Dussaix, E; Gerolami, V; Halfon, P; Buffet-Janvresse, C; Ferec, C; Mercier, B; Marcellin, P; Martinot-Peignoux, M; Gassain, M; Merel, P; Lamoril, J; Coste, J; Roudet-Thoraval, F
      Lessons from a multicentre study of the detectability of viral genomes based on a two-round quality control of GB virus C (GBV-C)/hepatitis G virus (HGV) polymerase chain reaction assay

      JOURNAL OF VIROLOGICAL METHODS
    11. Halfon, P; Halimi, G; Bourliere, M; Ouzan, D; Durant, J; Khiri, H; Mercier, L; Gerolami, V; Cartouzou, G
      Integrity of the NS5A (amino acid 2209 to 2248) region in hepatitis C virus 1b patients non-responsive to interferon therapy

      LIVER
    12. Debono, E; Halfon, P; Bourliere, M; Gerolami-Santandrea, V; Gastaldi, M; Castellani, P; Cartouzou, G; Botta-Fridlund, D; Cau, P; Gauthier, A
      Absence of hepatitis C genome in semen of infected men by polymerase chainreaction, branched DNA and in situ hybridization

      LIVER
    13. Bourliere, M; Halfon, P; Quentin, Y; David, P; Mengotti, C; Portal, I; Khiri, H; Benali, S; Perrier, H; Boustiere, C; Jullien, M; Lambot, G
      Covert transmission of hepatitis C virus during bloody fisticuffs

      GASTROENTEROLOGY
    14. Martinot-Peignoux, M; Roudot-Thoraval, F; Mendel, I; Coste, J; Izopet, J; Duverlie, G; Payan, C; Pawlotsky, JM; Defer, C; Bogard, M; Gerolami, V; Halfon, P; Buisson, Y; Fouqueray, B; Loiseau, P; Lamoril, J; Lefrere, JJ; Marcellin, P
      Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy

      JOURNAL OF VIRAL HEPATITIS
    15. Halfon, P; Cacoub, P
      Transmitted Transfusion Virus (TTV): a new hepatotropic virus ... looking for a disease

      PRESSE MEDICALE
    16. Halfon, P; Quentin, Y; Roquelaure, B; Sarles, J; Halimi, G; Gerolami, V; Khiri, H; Bourliere, M; Cartouzou, G
      Mother-to-infant transmission of hepatitis C virus: molecular evidence of superinfection by homologous virus in children

      JOURNAL OF HEPATOLOGY
    17. Durant, J; Clevenbergh, P; Halfon, P; Delgiudice, P; Porsin, S; Simonet, P; Montagne, N; Boucher, CAB; Schapiro, JM; Dellamonica, P
      Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial

      LANCET
    18. Mercier, B; Barclais, A; Botte, C; Cantalube, JF; Coste, J; Defer, C; Gautreau, C; Giannoli, C; Halfon, P; Lepot, I; Loiseau, P; Martial, J; Montcharmont, P; Merel, P; Ouzan, D; Ravera, N; Follana, J; Cesaire, R; Janot, C; Lemaire, JM; De Micco, P; Vezon, G; Ferec, C
      Prevalence of GBV C HGV RNA and GBV C HGV antibodies in French volunteer blood donors: Results of a collaborative study

      VOX SANGUINIS
    19. Periard, D; Telenti, A; Sudre, P; Cheseaux, JJ; Halfon, P; Reymond, MJ; Marcovina, SM; Glauser, MP; Nicod, P; Darioli, R; Mooser, V
      Atherogenic dyslipidemia in HIV-infected individuals treated with proteaseinhibitors

      CIRCULATION
    20. Cacoub, P; Halfon, P; Musset, L
      Transfusion-transmitted virus and mixed cryoglobulinemia

      ANNALS OF INTERNAL MEDICINE
    21. HALFON P; KHIRI H; FERYN JM; SAYADA C; CHANAS M; OUZAN D
      PROSPECTIVE VIROLOGICAL FOLLOW-UP OF HEPATITIS-C INFECTION IN A HEMODIALYSIS UNIT

      Journal of viral hepatitis
    22. DURANT J; CHANTRE P; GONZALEZ G; VANDERMANDER J; HALFON P; ROUSSE B; GUEDON D; RAHELINIRINA V; CHAMARET S; MONTAGNIER L; DELLAMONICA P
      EFFICACY AND SAFETY OF BUXUS SEMPERVIRENS L. PREPARATIONS (SPV30) IN HIV-INFECTED ASYMPTOMATIC PATIENTS - A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

      Phytomedicine
    23. RENOU C; HALFON P; PICON M; RIFFLET H; KHIRI A; JOUVE E; BERTRAND JJ; LAGIER M; DANTIN S; HYERES CH
      PROSPECTIVE EVALUATION OF THE INFLUENCE OF THE HLA CLASS-II ALLELES ON HEPATIC HISTOLOGY AND ON THE THERAPEUTIC RESPONSE AMONG PATIENTS WITH CHRONIC HEPATITIS-C

      Hepatology
    24. HALIMI CG; OUZAN D; HALFON P; SATTONET B; GEROLAMI V; CARTOUZOU G
      RELATIONSHIP BETWEEN THE HEMOCHROMATOSIS GENE, LIVER IRON OVERLOAD AND CHRONIC HEPATITIS

      Hepatology
    25. HALFON P; BOURLIERE M; KHIRI H; CHANAS M; SALVADORI JM; OUZAN D
      PREVALENCE OF TRANSMITTED TRANSFUSION VIRUS (TTV) IN DIFFERENT RISK POPULATIONS OF HEPATITIS-VIRUS - HEMODIALYSIS, CHRONIC HEPATITIS-C AND CRYPOGENETIC HEPATITIS PATIENTS

      Hepatology
    26. HALFON P; HALIMI G; KHIRI H; BOURLIERE M; OUZAN D; GEROLAMI V; CARTOUZOU G
      SEROLOGICAL RESPONSE TO INFECTION WITH DIFFERENT ISOLATES OF HEPATITIS-C VIRUS TYPES

      Hepatology
    27. HALFON P; GEROLAMI V; KHIRI H; BOURLIERE M; OUZAN D; HALIMI G; CARTOUZOU G
      EVALUATION OF THE COBAS AMPLICOR HCV MONITOR(TM) ASSAY - COMPARISON WITH THE BRANCHED DNA ASSAY

      Hepatology
    28. HALFON P; BOURLIERE M; HALIMI G; CARTOUZOU G; GEROLAMI V; RAABE JJ; RENOUX C; RIFLET H; QUZAN D
      MOLECULAR EPIDEMIOLOGY OF TRANSMISSION OF HEPATITIS-C VIRUS BETWEEN VIREAMIC REGULAR SPOUSES

      Hepatology
    29. OUZAN D; BALDINI E; SATTONNET C; KHIRI H; LONGO F; BRICHETTI A; HALFON P
      NATURAL-HISTORY OF HEPATITIS-C VIRUS (HCV) INFECTED PATIENTS - HISTOLOGICAL FOLLOW-UP OF VIREMIC SUBJECT WITH OR WITHOUT REPEATEDLY NORMAL AMINO TRANSFERASES ACTIVITY

      Hepatology
    30. CACOUB P; CAILLATZUCMAN S; KERR G; RENOU C; HALFON P; GHILLANI P; THIBAULT V; COHEN P; KAPLANSKI G; DURAND JM; MARTIN M; CARRINGTON M; PIETTE JC
      HLA HAPLOTYPES IN HEPATITIS-C VIRUS-ASSOCIATED MIXED CRYOGLOBULINEMIA

      Hepatology
    31. BOURLIERE M; HALIMI G; HALFON P; GEROLAMI V; BOTTA D; PORTAL I; GAUTHIER AP; CARTOUZOU G
      RESPONSE TO INTERFERON-RIBAVIRIN THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C - NS5A REGION (AA2209-2248) SEQUENCE-ANALYSIS

      Hepatology
    32. OUZAN D; BALDINI E; KHIRI H; BRICHETTI A; HALFON P
      DOSES ADJUSTMENT OF INTERFERON-ALPHA ACCORDING TO THE HCV-RNA RESPONSE IN CHRONIC HEPATITIS-C

      Hepatology
    33. GEROLAMI V; HALFON P; CHAMBOST H; THURET I; HALIMI G
      TRANSFUSION-TRANSMITTED VIRUS

      Lancet
    34. HALFON P; BOURLIERE M; HALIMI G; KHIRI H; BERTEZENE P; PORTAL I; BOTAFRIDLUND D; GAUTHIER AP; JULLIEN M; FERYN JM; GEROLAMI V; CARTOUZOU G
      ASSESSMENT OF SPONTANEOUS FLUCTUATIONS OF VIRAL LOAD IN UNTREATED PATIENTS WITH CHRONIC HEPATITIS-C BY 2 STANDARDIZED QUANTITATION METHODS - BRANCHED DNA AND AMPLICOR MONITOR

      Journal of clinical microbiology
    35. LONGO F; TRAN A; DURANT J; HALFON P; MANOS T; YANG G; OUZAN D; DELLAMONICA P; BENZAKEN S; RAMPAL P
      HEPATITIS-G VIRUS-INFECTION IN ANTI-HIV POSITIVE PATIENTS

      Gastroenterology
    36. ROTILY M; LOUBIERE S; NIXON J; BOURLIERE M; HALFON P; MOATTI JP
      SOCIOECONOMIC ANALYSIS OF VARIOUS SCREENI NG STRATEGIES FOR CHRONIC HEPATITIS-C IN A FRENCH POPULATION

      Gastroenterologie clinique et biologique
    37. CHAMBOST H; GEROLAMI V; HALFON P; THURET I; MICHEL G; SICARDI F; PERRIMOND H; CARTOUZOU G
      PERSISTENCE OF HEPATITIS-G VIRUS VIREMIA IN HEMOPHILIACS

      Thrombosis and haemostasis
    38. OUZAN D; HALFON P; BENZAKEN S; KHIRI H; BALDINI E; BRICHETTI A; TRAN A; SAYADA C; VIGUIERCASSUTO E
      MOLECULAR EVIDENCE AGAINST SEXUAL TRANSMISSION OF HEPATITIS-C VIRUS (HCV) FROM RENAL TRANSPLANTED PATIENT - COMPARISON WITH HEPATITIS-G VIRUS TRANSMISSION

      Hepatology
    39. OUZAN D; BALDINI E; KHIRI H; HALFON P
      PREDICTORS OF A SUBSTAINED BENEFICIAL (BIOCHEMICAL AND VIROLOGICAL) RESPONSE TO INTERFERON-ALPHA-2B THERAPY IN CHRONIC HEPATITIS-C - A PROSPECTIVE-STUDY

      Hepatology
    40. TRAN A; DURANT J; HALFON P; MANOS T; RAHELINIRINA V; CLEVENBERGH P; YANG G; OUZAN D; FOLLANA R
      HEPATITIS-C VIRUS (HGV) AND ANTI-HGV IN ANTI-HIV POSITIVE PATIENTS

      Hepatology
    41. HALFON P; POL S; SAYADA C; IZOPET J; ROSTAING L; OUZAN D
      CLINICAL-SIGNIFICANCE OF HCV RNA DETECTIO N AND QUANTITATION IN HEMODIALYSIS-PATIENTS - PROPOSAL FOR A RATIONAL DIAGNOSTIC STRATEGY

      Nephrologie
    42. HALFON P; BOURLIERE M; RAABE JJ; KHIRI H; GEROLAMI V; CARTOUZOU G; FERYN JM; OUZAN D
      TRANSMISSION OF HEPATITIS-G VIRUS IN HCV-INFECTED COUPLES - MYTH OR REALITY

      Journal of hepatology
    43. HALFON P; OUZAN D; KHIRI H; FERYN JM; DESMORAT H; BOURLIERE M; BOYER N; FONTANGES T; MATHIEUCHANDELIER C; JACQUES JP; BAESJOUR S; ROUHIER D; LOUVET H; HANSLIK B; BEORCHIA S; ANTONI M; BRUNERIE M; CORCOS D; RICHARDMOLARD B; PIERRUGUES R; CAUCANAS J; JOUANOLLE H
      SEROTYPING AND GENOTYPING OF HEPATITIS-C VIRUS (HCV) STRAINS IN CHRONIC HCV INFECTION

      Journal of medical virology
    44. BOGARD M; BUFFETJANVRESSE C; CANTALOUBE JF; BIAGINI P; DUVERLIE G; CASTELAIN S; IZOPET J; DUBOIS M; DEFER C; LEPOT I; COSTE J; MARCELLIN P; MARTINOTPEIGNOUX M; HALFON P; GEROLAMI V; FRANGUEL L; PAWLOTSKY JM; ROUDOTTHORAVAL F; DUSSAIX E; LOISEAU P; RAVERA N; LEWIN P; LAMORIL J; LERABLE J; BOUCHARDEAU F; LAPERCHE S; MARIOTTI M; LEFRERE JJ; NICOT T; DENIS F; GASSAIN M; MEREL P; TREPO C; THIERS V; BRECHOT C; FEREC C; MERCIER B; STOLLKELLER F; PALMER P; LEBON P
      GEMHEP MULTICENTER QUALITY-CONTROL STUDY OF PCR DETECTION OF GB-VIRUS-C HEPATITIS-G VIRUS-RNA IN SERUM

      Journal of clinical microbiology
    45. GEROLAMI V; HALFON P; CHAMBOST H; SICARDI F; THURET I; PLANELLS R; HALIMI G; FOSSAT C; MICHEL G; CARTOUZOU G
      PREVALENCE OF HEPATITIS-G VIRUS-RNA IN A MONOCENTRIC POPULATION OF FRENCH HEMOPHILIACS

      British Journal of Haematology
    46. Lunel, F; Poinsot, H; Bogard, M; Brechot, C; Defer, C; Duverlie, G; Fouqueray, B; Halfon, P; Lewine, P; Loiseau, P; Marcellin, P; Zarski, JP; Stuyver, L
      Prevalence and characteristics of genotype 2 subtypes in France

      HEPATITIS C VIRUS: GENETIC HETEROGENEITY AND VIRAL LOAD
    47. Halfon, P; Khiri, H; Gerolami, V; Alimi, JP; Halimi, G; Feryn, JM; Legros, S; Bourliere, M; Sarles, J; Cartouzou, G
      Molecular evidence of mother-to-infant transmission of hepatitis C by quasispecies analysis

      HEPATITIS C VIRUS: GENETIC HETEROGENEITY AND VIRAL LOAD
    48. HALFON P; LEVY M; SANMARCO M; GEROLAMI V; KHIRI H; BOURLIERE M; FERYN JM; GASTAUT JL; POUGET J; CARTOUZOU G
      MYASTHENIA-GRAVIS AND HEPATITIS-C VIRUS-INFECTION

      Journal of viral hepatitis
    49. HALIMI G; HALFON P; GEROLAMI V; CASTETS F; KHIRI H; BOURLIERE M; GAUTHIER AP; CARTOUZOU G
      MUTATIONS IN NS5A REGION AND ET INTERFERON RESPONSE IN HEPATITIS 1B INFECTED PATIENTS

      Hepatology
    50. OUZAN D; HALFON P; BENZAKEN S; KHIRI H; YVERNIN H; BRICHETTI A; TRAN A; SAYADA C; VIGUIERCASSUTO E
      INTRAFAMILIAL TRANSMISSION OF HEPATITIS-C VIRUS FROM RENAL TRANSPLANTED PATIENTS

      Hepatology
    51. DEBONO E; HALFON P; GEROLAMISANTANDREA V; GASTALDIPLANNELS M; CASTELLANI P; BOURLIERE M; CARTOUZOU G; GAUTHIER A; BOTTAFRIDLUND D
      SEXUAL TRANSMISSION OF HEPATITIS-C VIRUS (HCV) - DETECTION OF HCV IN SEMEN AND CORRELATION WITH PLASMA VIRAL LOAD

      Hepatology
    52. GEROLAMI V; HALFON P; CHAMBOST H; WARTELLE C; HALIMI G; KHIRI H; SICARDI F; PERRIMOND H; CARTOUZOU G
      PREVALENCE OF HEPATITIS-G VIRUS-INFECTION IN HEMOPHILIAC PATIENTS

      Hepatology
    53. HALFON P; KHIRI H; GEROLAMI V; HALIMI G; ALIMI JP; FERYN JM; BOURLIERE M; SARLES J; CARTOUZOU G
      MOLECULAR EVIDENCE OF INTRAFAMILLIAL AND MOTHER-TO-INFANT TRANSMISSION OF HEPATITIS-C BY QUASI-SPECIES ANALYSIS

      Hepatology
    54. OUZAN D; DESMORAT H; BOURLIERE M; BALDINI E; BOYER N; FONTANGES T; MATHIEUCHANDELIER C; JACQUES JP; BAESJOU S; ROUHIER D; LOUVET H; HANSLIK B; BEORCHIA S; ANTONI M; BRUNERIE M; CORCOS D; RICHARDMOLARD B; PIERRUGUES R; CAUCANAS J; JOUANOLLE H; DUMANOIR C; LANGLOIS C; LEMONNIER C; KHIRI H; BRICHETTI A; HALFON P
      SUSTAINED RESPONSE TO INTERFERON-ALFA 2B IS AFFECTED BY DOSE AND DURATION OF THERAPY - PRELIMINARY-RESULTS OF A FRENCH MULTICENTER RANDOMIZED TRIAL

      Hepatology
    55. OUZAN D; HALFON P; KHIRI H; FERYN JM; BRICHETTI A; SAYADA C
      ELIMINATION OF VIREMIA IN CHRONIC HEPATITIS-C BY INCREASED DOSES OF INTERFERON, MONITORED BY PCR

      Hepatology
    56. WARTELLE C; GEROLAMI V; PLANELLS R; CASTELLANI P; BOURLIERE M; DEBONNE JM; BARONI JL; HALFON P; BOTTAFRIDLUND D; CARTOUZOU G; GAUTHIER AP
      PREVALENCE AND IMPACT OF HEPATITIS-G VIRUS (HGV) INFECTION IN PATIENTS WITH CHRONIC HEPATITIS-C

      Hepatology
    57. WARTELLE C; NICOLINO C; BOURLIERE M; PORTAL I; BERNARDINI D; GUISSET M; PICON M; BARONI JL; BOTTAFRIDLUND D; GEROLAMI V; HALFON P; CARTOUZOU G; GAUTHIER AP
      DO WE NEED PRETHERAPEUTIC DETERMINATION OF THYROID PEROXYDASE ANTIBODY (ANTI-TPO) IN PATIENTS WITH CHRONIC HEPATITIS-C

      Hepatology
    58. HALFON P; KHIRI H; GEROLAMI V; BOURLIERE M; FERYN JM; REYNIER P; GAUTHIER A; CARTOUZOU G
      IMPACT OF VARIOUS HANDLING AND STORAGE-CONDITIONS ON QUANTITATIVE DETECTION OF HEPATITIS-C VIRUS-RNA

      Journal of hepatology
    59. DEMONTMARIN F; HARDY P; LEPINE JP; HALFON P; FELINE A
      6-MONTH AND LIFETIME PREVALENCES OF PSYCHIATRIC-DISORDERS IN INPATIENTS WITH DIABETES-MELLITUS

      European psychiatry
    60. REY JF; HALFON P; FERYN JM; KHIRI H; MASSEYEFF MF; OUZAN D
      TRANSMISSION OF VIRUS-C DURING ENDOSCOPIC EXAMINATION

      Gastroenterologie clinique et biologique
    61. BOURLIERE M; HALFON P; BERTHEZENE P; KHIRI H; PORTAL I; WARTELLE C; GEROLAMI V; CARTOUZOU G; GAUTHIER AP
      SPONTANEOUS FLUCTUATIONS OF VIRAL LOAD IN UNTREATED PATIENTS WITH CHRONIC HEPATITIS-C

      Hepatology
    62. HALFON P; OUZAN D; KHIRI H; CHANAS M; SALVADORI JM
      PROSPECTIVE VIROLOGICAL FOLLOW-UP OF HEPATITIS-C VIRUS-INFECTION IN HEMODIALYSIS DEPARTMENT

      Hepatology
    63. HALFON P; LEVY M; SANMARCO M; GEROLAMI V; KHIRI H; GASTAUT JL; CARTOUZOU G
      MYASTHENIA-GRAVIS AND HEPATITIS-C VIRUS-INFECTION

      Hepatology
    64. HALFON P; OUZAN D; KHIRI H; BOURLIERE M; GEROLAMI V; SAYADA C; CARTOUZOU G
      VIROLOGICAL DIAGNOSIS OF HCV INFECTION - PROPOSITION OF A DIAGNOSTIC ALGORITHM

      Hepatology
    65. OUZAN D; KHIRI H; BALDINI E; BRICHELLI A; SAYADA C; HALFON P
      COMPARATIVE-EVALUATION OF HCV VIREMIA BY USING A QUANTITATIVE PCR ANDBRANCHED-CHAIN DNA ASSAYS IN 98 CHRONIC HEPATITIS-C PATIENTS

      Hepatology
    66. OUZAN D; CHANAS M; BALDINI E; HALFON P; MANGIN L; BRICHETTI A; SALVADORI JM
      THE EFFECT OF URSODEOXYCHOLIC ACID (UDCA) ON LIVER SERUM ENZYMES IN HEMODIALYZED PATIENTS WITH CHRONIC C VIRAL-INFECTION

      Hepatology
    67. OUZAN D; KHIRI H; BALDINI E; FERYN JM; BRICHETTI A; HALFON P
      THE INTEREST OF MEASURING PLASMA GST IN PATIENTS ON DIALYSIS, INFECTED WITH THE HEPATITIS-C VIRUS (HCV)

      Hepatology
    68. PORTA I; BOURLIERE M; HALFON P; GEROLAMI V; WARTELLE C; KHIRI H; GARNIER PP; CASTELLANI P; ANTONI M; BOTTAFRIDLUND D; GAUTHIER AP; CARTOUZOU G
      VARIATIONS OF VIRAL LOAD AND GENOTYPES AFTER IFN THERAPY IN CHRONIC HEPATITIS-C

      Gastroenterology
    69. CHAMBOST H; GEROLAMI V; HALFON P; THURET I; MICHEL G; SICARDI F; ROUSSEAU S; PERRIMOND H; CARTOUZOU G
      PERSISTENT HEPATITIS-C VIRUS-RNA REPLICATION IN HEMOPHILIACS - ROLE OF COINFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS

      British Journal of Haematology
    70. SABRAN V; HARDY P; HALFON P; FELINE A
      MENTALLY DRUGS REPRESENTATION

      Annales medico-psychologiques
    71. PORTAL I; BOURLIERE M; HALFON P; GOROLAMI V; KHIRI H; CARTOUZOU G; GARNIER PP; CASTELLANI P; ANTONI M; BOTTAFRIDLUND D; GAUTHIER AP
      PREDICTIVE VALUE OF SERUM HCV RNA LEVELS AND GENOTYPES FOR RESPONSE TO INTERFERON-ALFA THERAPY

      Hepatology
    72. IZOPET J; BOGARD M; COSTES J; DUVERLIE G; HALFON P; OUZAN D; PUEL J; SAYADA C
      MULTICENTER EVALUATION OF ANALYTICAL PERFORMANCES OF THE AMPLICOR(TM)HCV RNA QUALITATIVE ASSAY

      Hepatology
    73. HALFON P; OUZAN D; KHIRI H; TIRTAINE C; FERYN JM; LEDINH P; HALIMI JP; FOLLANA R; SAYADA C
      INTEREST OF HCV RNA SCREENING IN HCV SERONEGATIVE BLOOD-DONORS WITH ELEVATED ALT

      Hepatology
    74. HALFON P; OUZAN D; KHIRI H; CHANAS M; FERYN JM; LEDINH P; HALIMI JP; MASSEYEF MF; SAYADA C; SALVADORI JM
      VALUE OF HCV RNA DETECTION IN SERONEGATIVE HEMODIALYZED PATIENTS

      Hepatology
    75. HALFON P; OUZAN D; CHANAS M; KHIRI H; FERYN JM; MANGIN L; MASSEYEF MF; SALVADORI JM
      UNEXPECTED HIGH PREVALENCE OF HEV ANTIBODY IN HEMODIALYSIS-PATIENTS

      Hepatology
    76. OUZAN D; SATTONET C; BALDINI E; BRICHETTI A; KHIRI H; FERYN JM; BONN JP; HALFON P
      HCV RNA QUANTITATIVE LEVELS IN CHRONIC HEPATITIS-C PATIENTS IN FRANCE- CORRELATION WITH ALT LEVELS AND SEVERITY OF HEPATIC HISTOLOGY

      Hepatology
    77. OUZAN D; MANGIN L; CHANAS M; HALFON P; SALVADORI JM
      ROLE OF HCV INFECTION ON IMMUNE-RESPONSE TO HEPATITIS-B VACCINATION IN HEMODIALYZED PATIENTS FOR CHRONIC-RENAL-FAILURE

      Hepatology
    78. OUZAN D; HALFON P; BALDINI E; CHANAS M; KHIRI H; MANGINI L; FERYN JM; BONN JP; SALVADORI JM
      SERUM HEPATITIS-C VIRUS (HCV) LEVELS AND GENOTYPES IN FRENCH HEMODIALYZED PATIENTS - SIGNIFICANCE AND THERAPEUTIC IMPLICATIONS

      Hepatology
    79. OUZAN D; HALFON P; KHIRI H; TIRTAINE C; MANGIN L; FERYN JM; FOLLANA R
      INTEREST OF HEV ANTIBODY SCREENING IN FRENCH BLOOD-DONORS WITH ELEVATED ALT

      Hepatology
    80. LEBRAS P; DOIRON R; QUERTAINMONT Y; HALFON P; CAQUET R
      METABOLIC, HEPATIC AND MUSCULAR CHANGES DURING ZIDOVUDINE THERAPY - ADRUG-INDUCED MITOCHONDRIAL DISEASE

      AIDS
    81. HALFON P; OUZAN D; CHANAS M; KHIRI H; FERYN JM; MANGIN L; MASSEYEF MF; SALVADORI JM
      HIGH PREVALENCE OF HEPATITIS-E VIRUS-ANTIBODY IN HEMODIALYSIS-PATIENTS

      Lancet
    82. BOURLIERE M; PORTAL I; HALFON P; LEBREUIL G; GEROLAMI V; KHIRI H; CARTOUZOU G; GARNIER PP; CASTELLANI P; ANTONI M; BOTTAFRIDLUND D; GAUTHIER AP
      RELATION BETWEEN LIVER HISTOLOGY AND SERUM HEPATITIS-C VIRUS-RNA LEVELS IN CHRONIC HEPATITIS-C DURING INTERFERON-ALFA THERAPY

      Gastroenterology
    83. GEROLAMI V; HALFON P; SANMARCO M; KHIRI H; BOURLIERE M; PORTAL I; GARNIER PP; CARTOUZOU G
      HEPATITIS-C VIRUS GENOTYPES IN FRENCH PATIENTS WITH AUTOIMMUNE HEPATITIS TYPE-II

      Gastroenterology
    84. HALFON P; TRAN A; OUZAN D; KHIRI H; FERYN JM; QUARANTA JF; BENZAKEN S; DREYFUS G; RAMPAL P
      HEPATITIS-C VIRUS (HCV) GENOTYPES IN PATIENTS WITH CHRONIC HEPATITIS-C AND ANTITHYROID AUTOANTIBODIES

      Gastroenterology
    85. HYRAILLES V; LARREY D; BLANC P; DUBOIS A; GEROLAMI V; COSTES J; HALFON P; DUCOS A; LARTOUZOU G; MICHEL H
      EVIDENCES FOR THE EXISTENCE OF HEALTHY CARRIERS OF HEPATITIS-C VIRUS (HCV) - CORRELATION WITH HCV GENOTYPE-I

      Gastroenterology
    86. PORTAL I; BOURLIERE M; HALFON P; GEROLAMI V; KHIRI H; CARTOUZOU G; GARNIER PP; CASTELLANI P; ANTONI M; BOTTAFRIDLUND D; GAUTHIER AP
      PREDICTIVE VALUE OF SERUM HEPATITIS-C VIRUS-RNA LEVELS DURING INTERFERON-ALFA THERAPY

      Gastroenterology
    87. GEROLAMI V; HALFON P; BOURLIERE M; KHIRI H; REYNIER P; GARNIER PP; PORTAL I; GAUTHIER A; CARTOUZOU G
      HEPATITIS-C VIRUS GENOTYPES IN CHRONIC HEPATITIS AND RESPONSE TO INTERFERON-ALPHA THERAPY

      The Journal of infectious diseases
    88. REY JF; MASSEYEF MF; HALFON P; FERYN JM; OUZAN D
      TRANSMISSION OF VIRUS C-HEPATITIS DURING ENDOSCOPY - EFFECTIVENESS OFCLEANING PROCEDURE

      Gastrointestinal endoscopy


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/05/20 alle ore 23:10:08